Operating Margin of Aclaris Therapeutics, Inc. from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Aclaris Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • Aclaris Therapeutics, Inc. Operating Margin for the quarter ending 30 Sep 2025 was -974%, a 470% decline year-over-year.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)

Aclaris Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -974% -803% -470% 01 Jul 2025 30 Sep 2025
Q2 2025 -873% -663% -315% 01 Apr 2025 30 Jun 2025
Q1 2025 -794% -516% -186% 01 Jan 2025 31 Mar 2025
Q4 2024 -758% -447% -143% 01 Oct 2024 31 Dec 2024
Q3 2024 -171% +400% +70% 01 Jul 2024 30 Sep 2024
Q2 2024 -211% +148% +41% 01 Apr 2024 30 Jun 2024
Q1 2024 -278% +50% +15% 01 Jan 2024 31 Mar 2024
Q4 2023 -312% -10% -3.2% 01 Oct 2023 31 Dec 2023
Q3 2023 -571% -215% -60% 01 Jul 2023 30 Sep 2023
Q2 2023 -358% +995% +74% 01 Apr 2023 30 Jun 2023
Q1 2023 -327% +917% +74% 01 Jan 2023 31 Mar 2023
Q4 2022 -302% +1025% +77% 01 Oct 2022 31 Dec 2022
Q3 2022 -356% +819% +70% 01 Jul 2022 30 Sep 2022
Q2 2022 -1353% -289% -27% 01 Apr 2022 30 Jun 2022
Q1 2022 -1244% -311% -33% 01 Jan 2022 31 Mar 2022
Q4 2021 -1327% -542% -69% 01 Oct 2021 31 Dec 2021
Q3 2021 -1175% -260% -28% 01 Jul 2021 30 Sep 2021
Q2 2021 -1064% +152% +13% 01 Apr 2021 30 Jun 2021
Q1 2021 -933% +1344% +59% 01 Jan 2021 31 Mar 2021
Q4 2020 -785% +1842% +70% 01 Oct 2020 31 Dec 2020
Q3 2020 -915% +467% +34% 01 Jul 2020 30 Sep 2020
Q2 2020 -1217% +117% +8.8% 01 Apr 2020 30 Jun 2020
Q1 2020 -2277% -1445% -174% 01 Jan 2020 31 Mar 2020
Q4 2019 -2627% -1742% -197% 01 Oct 2019 31 Dec 2019
Q3 2019 -1383% -56% -4.3% 01 Jul 2019 30 Sep 2019
Q2 2019 -1334% +41% +3% 01 Apr 2019 30 Jun 2019
Q1 2019 -832% 01 Jan 2019 31 Mar 2019
Q4 2018 -885% 01 Oct 2018 31 Dec 2018
Q3 2018 -1326% 01 Jul 2018 30 Sep 2018
Q2 2018 -1375% 01 Apr 2018 30 Jun 2018

Aclaris Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2017 -3230% 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.